With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The goal: to help bridge “silos of knowledge” into conciliated structured knowledge linking metabolism, signaling, electrophysiology and mechanics, and mathematical models.
A global exchange for cardiovascular scientists and clinicians
Harnessing Inflammation Pathways and Membrane Lipidomics for Stem Cell Biomanufacturing and Regenerative Engineering
RIP inflammation: Novel inflammatory drivers of obesity & cardiometabolic diseases
Heart regeneration with human pluripotent stem cell-derived cardiomyocytes
Title: "The use of randomized cardiovascular surgical trials to distort best clinical practice." Location: Sunnybrook Health Sciences Centre - Room E-315 Learning objectives: To understand the principles and rationale for […]
Keynote: Dr. Donald Ingber (Harvard) -- “Catalyzing the Next Technology Wave: Biologically Inspired Engineering at the Wyss Institute.”
Synthetic human embryology in a dish
This annual conference will focus on cardiac myxoma in 2018